Purchase Order 36C24226P0216
- Not listed
- Novocure Inc. was awarded a $49,748.73 firm fixed-price purchase order by the Department of Veterans Affairs' Veterans Integrated Service Network 7 on November 5, 2025, for Optune Plus transducers. The contract, which carries no set-aside designation, is scheduled for completion by February 27, 2026, and will be performed in Portsmouth, New Hampshire. This award represents a delivery order under Novocure's existing Federal Supply Schedule contract with the VA Veterans Health Administration for...
- Novocure Inc. was awarded a $49,748.73 firm fixed-price purchase order by the Department of Veterans Affairs Veterans Integrated Service Network 20 on November 17, 2025, for custom Optune Plus transducers. The contract, with performance in Portsmouth, NH, is not set-aside designated and carries an ultimate completion date of November 16, 2026. This award represents a delivery order under Novocure's existing Federal Supply Schedule contract with the VA VHA for Medical Equipment and Supplies...
- Novocure Inc. was awarded a firm fixed-price purchase order valued at $49,748.73 by the Department of Veterans Affairs' Veterans Integrated Service Network 20 (VISN 20) on November 13, 2025, for Optune Plus transducers. The contract, which carries an ultimate completion date of November 12, 2026, will be performed in Portsmouth, New Hampshire. This award represents delivery of specialized medical device components under Novocure's existing Federal Supply Schedule contract with the VA Veterans...
- Novocure Inc. has been awarded a $49,748.73 firm fixed price purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 to provide transducers and related equipment rentals and services. As the prime contractor, Novocure will deliver its Optune tumor treating fields therapy devices, transducer arrays, and support directly to the VA medical center located in Portsmouth, New Hampshire. Additionally, Novocure holds a five-year, $28.85...
- Novocure Inc. has been awarded a delivery order valued at $49,748.73 for Optune Plus transducers under a firm fixed-price contract with the Veterans Integrated Service Network 1, a civilian agency within the Department of Veterans Affairs. The award, issued on November 25, 2025, with completion scheduled for February 25, 2026, represents performance at a Portsmouth, New Hampshire location. This delivery order is issued under Novocure's existing Federal Supply Schedule contract for Medical...
- Novocure Inc. has been awarded a firm fixed price purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7. The contract is for $49,748.73 to provide Optune Plus Transducers with no set-aside designation. As the prime contractor, Novocure will deliver its Optune tumor treating fields therapy devices and transducer arrays directly to the VA medical center located in Portsmouth, New Hampshire by May 31, 2024. Additionally, Novocure...
- Novocure Inc. was awarded a delivery order valued at $49,748.73 for Optune Plus transducers by the Department of Veterans Affairs' Veterans Integrated Service Network 10, with an ultimate completion date of January 20, 2026. The award, issued on October 20, 2025, operates under a firm fixed-price contract structure with no set-aside designation. The delivery order stems from Novocure's broader General Services Administration Federal Supply Schedule contract for Medical Equipment and Supplies...
- This federal contract award is for the delivery of Novocure Inc.'s Optune Plus transducers to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $49,748.73 firm fixed-price purchase order was awarded on December 4, 2023 with an ultimate completion date of the same day. The contract does not utilize any set-aside designations. Novocure Inc. is a foreign-owned, for-profit manufacturer of medical devices specializing in cancer therapy using its proprietary...
- The Department of Veterans Affairs, Veterans Integrated Service Network 15 (VISN 15), awarded a $49,748.73 firm fixed-price purchase order to Novocure Inc. on October 30, 2025, for the rental of Optune Plus transducers. The contract, with an ultimate completion date of March 31, 2026, will be performed in Portsmouth, New Hampshire. Novocure Inc., a foreign-owned medical device manufacturer specializing in Tumor Treating Fields (TTFields) technology, will provide non-invasive cancer treatment...
- Novocure Inc. has been awarded a $49,748.73 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 to provide Optune Plus transducers. As the prime contractor, Novocure will deliver its proprietary Optune tumor treating fields therapy devices, transducer arrays, and related equipment rentals and services directly to the VA medical center located in Portsmouth, New Hampshire. This delivery order is being issued...
Novocure Inc. has been awarded a $49.7K firm fixed-price purchase order by Veterans Integrated Service Network 2, funded through the Department of Veterans Affairs, for Optune Plus transducers. The contract, with an ultimate completion date of December 10, 2025, represents a non-competitive procurement of prosthetic medical devices for the VA Portsmouth medical facility in New Hampshire. This award carries no set-aside designation, consistent with Novocure's contracting pattern with the VA, as the company's specialized medical device technologies typically do not qualify for small business or other preferential procurement set-asides. This purchase order is issued under Novocure's existing Federal Supply Schedule contract (Medical Equipment and Supplies category) with the VA Veterans Health Administration, valued at $28.85M and running through October 31, 2027. Novocure, a foreign-owned medical device manufacturer, specializes in the Optune system, which uses Tumor Treating Fields technology to treat solid tumors including glioblastoma and mesothelioma. The company serves as the prime contractor on this delivery order without utilizing subcontractors, directly providing the FDA-approved transducers and associated support services that enable VA medical centers to offer non-invasive cancer treatment options to veteran patients.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.7k | 12/10/25 |